FeNO by NIOX® USA

FeNO by NIOX® USA is a division of NIOX Group plc, focused on developing and distributing medical devices for asthma diagnosis and management. Their main product, the NIOX VERO®, is a non-invasive device that measures fractional exhaled nitric oxide (FeNO) levels in patients' breath. This measurement helps healthcare professionals accurately diagnose and manage asthma by providing clear insights into airway inflammation. The company offers advanced FeNO testing technology that enhances the quality of asthma care. The NIOX VERO® device is designed for ease of use, featuring visual and audio aids to assist patients during testing. FeNO by NIOX® USA serves healthcare professionals, including pulmonologists, allergists, and primary care providers, and their products are available in over 50 countries, supported by local teams and distributor networks. With operations in the United States, the United Kingdom, Germany, Sweden, and China, the company ensures strong regional support and customer service.

• Employees 8
• Founded 2006